SCHEMBL23259787

SCHEMBL23259787

O=c1cc(-c2ccc(OCCCN3CCCC3)cc2)[nH]c2ccccc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 15/20 0.71
CTSV O60911 2/20 0.69
CTSL P07711 2/20 0.69
KDM4E B2RXH2 2/20 0.56
LMNA P02545 2/20 0.56
HPGD P15428 2/20 0.56
ALDH1A1 P00352 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
KCNH2 Q12809 4/20 0.55
HRH1 P35367 1/20 0.55
ADRA1A P35348 2/20 0.52
TUBB4A P04350 1/20 0.51
TP53 P04637 1/20 0.51
TUBB P07437 1/20 0.51
TUBA3C P0DPH7 1/20 0.51
TUBA1B P68363 1/20 0.51
TUBA4A P68366 1/20 0.51
TUBB4B P68371 1/20 0.51
TUBB3 Q13509 1/20 0.51
TUBB2A Q13885 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29712365 1.00 HRH3 (0.71) HRH3CTSVCTSLKDM4ELMNA
SCHEMBL29712363 0.99 HRH3 (0.72) HRH3CTSVCTSLKDM4ELMNA
SCHEMBL23259788 0.99 HRH3 (0.72) HRH3CTSVCTSLKDM4ELMNA
SCHEMBL6301198 0.83 HRH3 (1.00) HRH3KCNH2HRH1HRH4
SCHEMBL23259715 0.82 CTSV (0.81) CTSVCTSLKDM4ELMNAHPGD
SCHEMBL29712383 0.82 CTSV (0.81) CTSVCTSLKDM4ELMNAHPGD
SCHEMBL23259585 0.79 HRH3 (0.55) HRH3KDM4EALDH1A1SMN1; SMN2KCNH2
SCHEMBL29712381 0.79 HRH3 (0.55) HRH3KDM4EALDH1A1SMN1; SMN2KCNH2
SCHEMBL23259587 0.78 HRH3 (0.56) HRH3KCNH2HRH1ADRA1AHRH4
SCHEMBL30025655 0.78 HRH3 (0.56) HRH3KCNH2HRH1ADRA1AHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295134-A1 USE OF PHENYLQUINOLINONE DERIVATIVE OR FLAVONOID DERIVATIVE FOR TREATING NEUROPATHIC PAIN HANGZHOU BIO-SINCERITY PHARMA-TECH CO., LTD. (CN) 2023-09-21 US disclosed
US-20230295134-A1 USE OF PHENYLQUINOLINONE DERIVATIVE OR FLAVONOID DERIVATIVE FOR TREATING NEUROPATHIC PAIN HANGZHOU BIO-SINCERITY PHARMA-TECH CO., LTD. (CN) 2023-09-21 US disclosed
US-20230295134-A1 USE OF PHENYLQUINOLINONE DERIVATIVE OR FLAVONOID DERIVATIVE FOR TREATING NEUROPATHIC PAIN HANGZHOU BIO-SINCERITY PHARMA-TECH CO., LTD. (CN) 2023-09-21 US disclosed
WO-2021072642-A1 USE OF PHENYLQUINOLINONES AND FLAVONOID DERIVATIVES FOR TREATING NEUROPATHIC PAIN 杭州百诚医药科技股份有限公司 2021-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295134-A1 USE OF PHENYLQUINOLINONE DERIVATIVE OR FLAVONOID DERIVATIVE FOR TREATING NEUROPATHIC PAIN HRH4, HRH2, HRH1 HRH3 7/4885CTSV 882/4885CTSL 3208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.